vs
Side-by-side financial comparison of USANA HEALTH SCIENCES INC (USNA) and Vroom, Inc. (VRM). Click either name above to swap in a different company.
Vroom, Inc. is the larger business by last-quarter revenue ($235.9M vs $226.2M, roughly 1.0× USANA HEALTH SCIENCES INC). USANA HEALTH SCIENCES INC runs the higher net margin — 0.1% vs -59.8%, a 59.9% gap on every dollar of revenue. On growth, Vroom, Inc. posted the faster year-over-year revenue change (12.9% vs -10.0%). Over the past eight quarters, USANA HEALTH SCIENCES INC's revenue compounded faster (3.1% CAGR vs -49.5%).
Usana Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, Usana was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 24 countries via a network of independent distributors.
Vroom, Inc. is a parent company of United Auto Credit Corporation (UACC) and CarStory. Previously, Vroom was a used car retailer and e-commerce company that let consumers buy, sell, and finance cars online. Vroom ceased e-commerce automotive sales operations on January 22, 2024.
USNA vs VRM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2023
| Metric | | |
|---|---|---|
| Revenue | $226.2M | $235.9M |
| Net Profit | $180.0K | $-141.1M |
| Gross Margin | 78.2% | 12.3% |
| Operating Margin | 1.7% | -11.5% |
| Net Margin | 0.1% | -59.8% |
| Revenue YoY | -10.0% | 12.9% |
| Net Profit YoY | -74.0% | -669.8% |
| EPS (diluted) | $-0.10 | $-80.66 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $226.2M | — | ||
| Q3 25 | $213.7M | — | ||
| Q2 25 | $235.8M | — | ||
| Q1 25 | $249.5M | — | ||
| Q4 24 | $213.6M | — | ||
| Q3 24 | $200.2M | — | ||
| Q2 24 | $212.9M | — | ||
| Q4 23 | — | $235.9M |
| Q4 25 | $180.0K | — | ||
| Q3 25 | $-6.5M | — | ||
| Q2 25 | $9.7M | — | ||
| Q1 25 | $9.4M | — | ||
| Q4 24 | $4.5M | — | ||
| Q3 24 | $10.6M | — | ||
| Q2 24 | $10.4M | — | ||
| Q4 23 | — | $-141.1M |
| Q4 25 | 78.2% | — | ||
| Q3 25 | 77.2% | — | ||
| Q2 25 | 78.7% | — | ||
| Q1 25 | 79.0% | — | ||
| Q4 24 | 82.0% | — | ||
| Q3 24 | 80.4% | — | ||
| Q2 24 | 81.1% | — | ||
| Q4 23 | — | 12.3% |
| Q4 25 | 1.7% | — | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | 7.1% | — | ||
| Q1 25 | 6.3% | — | ||
| Q4 24 | 3.8% | — | ||
| Q3 24 | 7.8% | — | ||
| Q2 24 | 8.4% | — | ||
| Q4 23 | — | -11.5% |
| Q4 25 | 0.1% | — | ||
| Q3 25 | -3.1% | — | ||
| Q2 25 | 4.1% | — | ||
| Q1 25 | 3.8% | — | ||
| Q4 24 | 2.1% | — | ||
| Q3 24 | 5.3% | — | ||
| Q2 24 | 4.9% | — | ||
| Q4 23 | — | -59.8% |
| Q4 25 | $-0.10 | — | ||
| Q3 25 | $-0.36 | — | ||
| Q2 25 | $0.52 | — | ||
| Q1 25 | $0.49 | — | ||
| Q4 24 | $0.23 | — | ||
| Q3 24 | $0.56 | — | ||
| Q2 24 | $0.54 | — | ||
| Q4 23 | — | $-80.66 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.4M | $135.6M |
| Total DebtLower is stronger | — | $454.2M |
| Stockholders' EquityBook value | — | $127.7M |
| Total Assets | $742.9M | $1.5B |
| Debt / EquityLower = less leverage | — | 3.56× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $158.4M | — | ||
| Q3 25 | $145.3M | — | ||
| Q2 25 | $151.3M | — | ||
| Q1 25 | $179.6M | — | ||
| Q4 24 | $181.8M | — | ||
| Q3 24 | $364.9M | — | ||
| Q2 24 | $332.4M | — | ||
| Q4 23 | — | $135.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | $454.2M |
| Q4 25 | — | — | ||
| Q3 25 | $528.1M | — | ||
| Q2 25 | $531.1M | — | ||
| Q1 25 | $529.8M | — | ||
| Q4 24 | $532.1M | — | ||
| Q3 24 | $533.1M | — | ||
| Q2 24 | $512.2M | — | ||
| Q4 23 | — | $127.7M |
| Q4 25 | $742.9M | — | ||
| Q3 25 | $726.6M | — | ||
| Q2 25 | $734.5M | — | ||
| Q1 25 | $746.6M | — | ||
| Q4 24 | $748.2M | — | ||
| Q3 24 | $671.3M | — | ||
| Q2 24 | $631.4M | — | ||
| Q4 23 | — | $1.5B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | 3.56× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-108.1M |
| Free Cash FlowOCF − Capex | — | $-108.8M |
| FCF MarginFCF / Revenue | — | -46.1% |
| Capex IntensityCapex / Revenue | — | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-536.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $-2.0M | — | ||
| Q2 25 | $12.2M | — | ||
| Q1 25 | $15.5M | — | ||
| Q4 24 | $5.8M | — | ||
| Q3 24 | $29.5M | — | ||
| Q2 24 | $8.0M | — | ||
| Q4 23 | — | $-108.1M |
| Q4 25 | — | — | ||
| Q3 25 | $-5.2M | — | ||
| Q2 25 | $7.2M | — | ||
| Q1 25 | $12.7M | — | ||
| Q4 24 | $4.0M | — | ||
| Q3 24 | $27.1M | — | ||
| Q2 24 | $5.3M | — | ||
| Q4 23 | — | $-108.8M |
| Q4 25 | — | — | ||
| Q3 25 | -2.4% | — | ||
| Q2 25 | 3.0% | — | ||
| Q1 25 | 5.1% | — | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 13.6% | — | ||
| Q2 24 | 2.5% | — | ||
| Q4 23 | — | -46.1% |
| Q4 25 | — | — | ||
| Q3 25 | 1.5% | — | ||
| Q2 25 | 2.1% | — | ||
| Q1 25 | 1.1% | — | ||
| Q4 24 | 0.8% | — | ||
| Q3 24 | 1.2% | — | ||
| Q2 24 | 1.3% | — | ||
| Q4 23 | — | 0.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.27× | — | ||
| Q1 25 | 1.65× | — | ||
| Q4 24 | 1.29× | — | ||
| Q3 24 | 2.78× | — | ||
| Q2 24 | 0.77× | — | ||
| Q4 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
